Trupanion Inc (TRUP) CEO Darryl Rawlings Sells 3,500 Shares
Trupanion Inc (NYSE:TRUP) CEO Darryl Rawlings sold 3,500 shares of the stock in a transaction on Tuesday, October 4th. The stock was sold at an average price of $16.21, for a total transaction of $56,735.00. Following the sale, the chief executive officer now directly owns 1,526,505 shares of the company’s stock, valued at approximately $24,744,646.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Trupanion Inc (NYSE:TRUP) opened at 15.98 on Thursday. The firm’s market cap is $463.66 million. The firm has a 50-day moving average of $15.82 and a 200-day moving average of $13.95. Trupanion Inc has a 52 week low of $6.27 and a 52 week high of $17.68.
Trupanion (NYSE:TRUP) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.06. The firm earned $45.83 million during the quarter, compared to analyst estimates of $45.05 million. The firm’s revenue for the quarter was up 28.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.17) EPS. On average, analysts expect that Trupanion Inc will post ($0.22) EPS for the current year.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Royal Bank of Canada increased its position in shares of Trupanion by 80.5% in the second quarter. Royal Bank of Canada now owns 64,450 shares of the company’s stock worth $854,000 after buying an additional 28,750 shares during the period. Stifel Financial Corp increased its position in Trupanion by 24.7% in the second quarter. Stifel Financial Corp now owns 14,200 shares of the company’s stock worth $189,000 after buying an additional 2,809 shares during the last quarter. Metropolitan Life Insurance Co. NY bought a new position in Trupanion during the second quarter worth about $160,000. AQR Capital Management LLC bought a new position in Trupanion during the second quarter worth about $146,000. Finally, A.R.T. Advisors LLC bought a new position in Trupanion during the second quarter worth about $166,000.
Several equities research analysts have recently issued reports on the stock. RBC Capital Markets set a $18.00 price objective on shares of Trupanion and gave the stock a “buy” rating in a research report on Tuesday, September 20th. Canaccord Genuity reissued a “buy” rating and set a $19.00 price objective on shares of Trupanion in a research report on Thursday, August 4th. Stifel Nicolaus increased their price objective on shares of Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. Zacks Investment Research downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Wednesday, July 27th. Finally, Lake Street Capital initiated coverage on shares of Trupanion in a research report on Tuesday, July 19th. They issued a “buy” rating and a $18.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $15.75.
Trupanion Company Profile
Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.
Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.